Lesinurad-13CD2

Lesinurad-13CD2 is listed under Stable Isotopes and is intended for analytical research, quality control and pharmaceutical reference standard applications. It is associated with Lesinurad. The product is supplied by Clearsynth under CAT No. CS-T-103466. Clearsynth provides this compound for research and analytical use, with product information including CAS number, molecular formula, molecular weight and product enquiry details.

Product Specifications

Overview

Isotope labelled Lesinurad is used to synthesize febuxostat which is a non-purine analog inhibitor of xanthine oxidase. Febuxostat is approved by the European Medicines Agency and the US Food and Drug Administration for treating gout.

Synonyms

Lesinurad-13CD2

Molecular Formula

C 1613 CH 12 D 2 BrN 3 O 2 S

Molecular Weight

407.29

Additionnal Information

Lesinurad-13CD2 is supplied with detailed characterization data compliant with regulatory guideline. Lesinurad-13CD2 can be used for analytical method development, method validation (AMV), Quality Control (QC) application for Abbreviated New Drug Application (ANDA), or during commercial production of Lesinurad.